Hypertension and Anti-hypertensive Agents Flashcards

1
Q

what is hypertension

A

high blood pressure
>140 systolic
>90 diastolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is arterial blood pressure

A
  1. proportional to the product of cardiac output (CO) + total peripheral resistance (TPR)
    - CO: product of heart rate and efficiency
    - TPR: elastic resistance of vessels + degree of vascular sm contraction
  2. blood pressure can be reduced by:
    - reducing CO
    - total blood volume
    - increasing blood vessel diameter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

effects of sympathetic and parasympathetic activity on cardiac tissue

A
  1. heart rate:
    - increased by symp NS
    - decreased by para NS = dominant
  2. contractile force:
    - increased by symp NS = dominant
    - decreased by para NS
  3. symp NS increases contraction of vascular sm
  4. symp NS increases renin release from kidneys
    = sodium + water retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are short term changes in blood pressure carried out by

A

baroreceptor reflex

stretch sensitive receptors imbedded in walls of carotid sinus/aortic arch => info about state of arterial contraction/relaxation -> delivered to medulla by afferent neurons

medulla send out stimulatory signals to activate symp/para NS => changes in HR/BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how to baroreceptors respond to increased BP

A

baroreceptors activity increases
sympathetic activity decreases
parasympathetic activity increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how to baroreceptors respond to decreased BP

A

baroreceptors activity decreases
sympathetic activity increases
parasympathetic activity decreases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are other BP regulators

A
  1. angiotensin II
  2. vasopressin
  3. prostaglandins
  4. endothelins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

angiotensin II

A

increases sympathetic response
decreases parasympathetic response
increases H20 retention
acts directly on vascular sm = vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

vasopressin

A

antidiuretic hormone

increases water retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

prostaglandins

A

vasoconstrictive/dilative eicosanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

endothelins

A

vasoconstrictive/dilative

paracrine: made in endothelial cells - act on vascular sm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

renin-angiotensin system

A
  1. renin is secreted by granular cells ling kidney arterioles in response to:
    - Na+ loss
    - decreased BP
    - sympathetic activity on kidneys
    - B agonists
    - PGI2
  2. renin converts angiotensinogen > angiotensin I
  3. angiotensin-converting enzyme (ACE) converts
    angiotensin I > angiotensin II
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

functions of angiotensin II

A
  1. increases vasopressin = fluid retention from kidney
  2. stimulates thirst
  3. potent vasoconstrictor
  4. acts on CNS - stimulate increased sympathetic outflow (NE)
  5. promotes Na+ retention by increasing aldosterone secretion

= INCREASE BLOOD PRESSURE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary hypertension

A

due to dysfunction of blood pressure regulation mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

secondary hypertension

A

due to diseases that inhibit the flexibility of peripheral blood vessels (diabetes, atherosclerosis) //
affect coronary output (coronary artery disease/congestive heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

diseases aggravated by high BP

A
atherosclerosis
congestive heart failure
stroke
renal disease
retinal detachment
Alzheimer's
17
Q

nonpharmacological treatment of high BP

A
weight reduction
exercise
quit smoking
reduce alcohol 
reduce sodium intake
reduce saturated fat intake
relaxation techniques
18
Q

drugs used to treat hypertension

A
  1. diuretics (increase urine)
  2. B-blockers (decrease BP/HR/E)
  3. a1 antagonists
  4. a2 partial agonists
  5. calcium channel blockers
  6. potassium channel activators
  7. ACE inhibitors
  8. angiotensin receptor antagonists
19
Q

what is the site of diuretic drug action

20
Q

symport

A

coupled transport of 2 or more substance across a membrane in same direction

21
Q

antiport

A

2 or more substances exchanged in opposite directions

22
Q

loop diuretics

A

inhibit Na+/K+/2Cl- symport by blocking reabsorption of Na+/K+/2Cl-
= flow of water blood to the lumen of Loop of Henle

used to treat hypertension associated with acute pulmonary edema and congestive heart disease

side effects: K+ and Mg2+ loss, uric acid retention

23
Q

thiazide diuretics

A

inhibit Na+Cl- symport in endothelial cells that line distal convoluted tubule

  • same effect as loop diuretics = LESS POTENT
    (less absorption of compounds in DCT - treat less severe hypertension)

side effects: K+ and Mg2+ loss, uric acid retention, hyperglycemia, erectile dysfunction

24
Q

what does K+ loss lead to

A

cardiac arrhythmias - block repolarisation phase of cardiac contraction

25
interactions of diuretics with other drugs
diuretics cause decreased lithium excretion via kidneys diuretics increase risk of cardiac glycoside-induced arrhythmias (digoxin) diuretics = less effective when taken with NSAIDs (aspirin)
26
B-blockers
reduction in cardiac output = competitive antagonism of B1 adrenergic receptors reduction in renin release from kidneys act on CNS - reduce sympathetic outflow PROPANOLOL (nonspecific - acts on B1/2 = block relaxation) Side effects: can worsen asthma/cause heart failure with congestive heart disease patients
27
a1 antagonists
block vasoconstrictive actions of a1 receptors in vascular sm DOXAZOSIN Side effects: first dose effect hypotension /impotence
28
a2 agonists
bind to a2 inhibitory autoreceptors in sympathetic neurons and medulla CLONIDINE Side effects: orthostatic hypotension, rebound hypertension
29
calcium channel blockers
block L-type Ca2+ channels in arterial sm = preventing vasoconstirction VERAPAMIL Side effects: cardiodepression/AV node block potential for many drug-drug interactions - ability to block p-glycoprotein efflux pump
30
potassium channel activator
sm relaxation = open K+ ATP channels in vascular sm, hyperpolarisation inhibits calcium entry stimulates renin release MINOXIDIL = decrease BP Side effects: stimulates hair growth cause fluid retention (coadministered with a loop diuretic) reflex tachycardia
31
ACE inhibitors
bind to active site of ACE reversible inhibition of angiotensin II converting enzyme best in patients with high levels of renin CAPTOPRIL Side effects: persistent cough, angioedema, teratogenic toxic drug interactions: increased risk of sudden death when combined with cotrimoxazole = hyperkalemia (K+ loss)
32
angiotensin II receptors antagonists
blocks binding of angiotensin II to AT1 angiotensin receptors (competitive) LOSARTAN Side effects: hypotension, headaches, GI upset - no cough = stronger than ACE inhibitors
33
why are most anti-hypertensive drugs used in combination with other bp lowering drugs
reduces dose needed to achieve desired BP allower lower value to be reach as opposed to single drug side effects reduced typical combination: diuretic + antihypertensive
34
pulmonary hypertension
elevated BP in pulmonary arteries (lungs 02 -> heart ) : pulmonary embolism, COPD, sleep apnea, heart defects, sickle cell anemia, cirrhosis of liver, AIDS treatment: diuretics, cardiac glycosides calcium channel blockers EPOPROSTENOL, AMBRISENTAN, SILDENAFIL
35
EPROPROSTENOL
prostacyclin: synthetic PGI2 binds to IP receptor = lowers cAMP formation + PKA activation PKA phosphorylates myosin light chain kinase = inhibits sm contraction => vasodilation lowers cytoplasmic Ca2+ blocks release of ET-1
36
AMBRISENTAN
competitive antagonist of endothelin- ET-1a/b receptors main target\: ET-1a R in sm = vasocontriction visa IP3=mediated Ca2+ release = teratogens
37
SILDENAFIL
phosphodiesterase V inhibitor phosphodiesterase V converts cGMP > GMP cGMP + NO activate a K+ channel in vascular sm
38
peripheral vascular disease
caused by atherosclerotic plaques treatment: antiplatelet drugs: ASPIRIN / CLOPIDOGREL cholesterol-lowering drugs: STATINS ACE inhibitors: CAPTOPRIL